![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Keeping the Pressure on Archived NRTI Resistance: Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Triple Therapy in Study 4030
|
|
|
Reported by Jules Levin
Mexico City IAS 2019 July 21-24
Rima Acosta, Madeleine Willkom, Kristen Andreatta, Hui Liu, Ross Martin, Aiyappa Parvangada, Hal Martin, Sean Collins, and Kirsten L. White Gilead Sciences, Inc., Foster City, CA, USA
![0724191](../images/072519/072519-12/0724191.gif)
![0724192](../images/072519/072519-12/0724192.gif)
![0724193](../images/072519/072519-12/0724193.gif)
![0724194](../images/072519/072519-12/0724194.gif)
![0724195](../images/072519/072519-12/0724195.gif)
![0724196](../images/072519/072519-12/0724196.gif)
![0724197](../images/072519/072519-12/0724197.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|